{"task_id": "4644d27d57a80168", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 62/464)", "text": "Late peaking of systolic murmur\nAortic Stenosis\n47\n\n--- Page 69 ---\nDISTINGUISHING FEATURES BETWEEN AORTIC STENOSIS, MITRAL REGURGITATION, AND HYPER\nTROPHIC CARDIOMYOPATHY\nAortic Stenosis\nMitral Regurgitation\nHOCM\nCarotid upstroke\nSlow, low amplitude\nNormal or low amplitude\nBrisk\nS1\nNormal\nSoft\nNormal\nS2\nSingle if severe\nNormal\nOften reversed\nS3\nNo\nLoud\nNo\nS4\nIf severe\nNo\nYes\nLoudest murmur\nRUSB\nApex\nLLSB and apex\nManeuvers\nStanding\n#\n#\n\"\nSquatting\n\"\n\"\n#\nValsalva\n#\n#\n\"\nINVESTIGATIONS\nBASIC\n\u0002 CXR\n\u0002\nECHOCARDIOGRAM\ntransthoracic\n\u0002 ECG\nleft ventricular hypertrophy\n\u0002\nEXERCISE TESTING\nSPECIAL\n\u0002\nCARDIAC CATHETERIZATION\nDIAGNOSTIC AND PROGNOSTIC ISSUES\nAORTIC VALVE AREA AND SEVERITY\n\u0002\nNORMAL = 3 4 cm2\n\u0002\nMILD = 1.5 2 cm2 or mean gradient <25 mmHg\n\u0002\nMODERATE\n=\n1 1.5\ncm2\nor\nmean\ngradient\n25 40 mmHg\n\u0002\nSEVERE = <1 cm2 or mean gradient >40 mmHg\n\u0002\nSYMPTOMS\nusually do not appear until valve\n<1 cm2. The significance of valve area depends\non patient size (larger patient = more severe for\nsame valve area)\n\u0002\nPROGRESSION\nvalve area decreases by \b0.1 cm2/\nyear and the mean gradient increases by 7 mmHg/\nyear (particularly if cardiac risk factors)\nPROGNOSIS\nOF\nAORTIC\nSTENOSIS\nwASHw\n(Angina, Syncope, Heart failure)\n\u0002\nSEVERE AORTIC STENOSIS WITH NO SYMPTOMS\n1 2%\ndie in short period\n\u0002\nSEVERE AORTIC STENOSIS WITH ANGINA PRESENTA-\nTION\n50% die in 5 years\n\u0002\nSEVERE AORTIC STENOSIS WITH SYNCOPE PRESENTA-\nTION\n50% die in 3 years\n\u0002\nSEVERE AORTIC STENOSIS WITH HEART FAILURE PRESEN-\nTATION\n50% die in 2 years\n\u0002\nSEVERE AORTIC STENOSIS AFTER VALVE REPLACEMENT\nsurvival similar to normal individuals\nMANAGEMENT\nMILD OR MODERATE AORTIC STENOSIS\nfollow\nclinically and with echocardiogram (every 3 5 years\nfor mild, every 1 2 years for moderate, every year for\nMANAGEMENT (CONT\u2019D)\nsevere). Statins may slow progression with early aor\ntic stenosis\nSEVERE OR SYMPTOMATIC AORTIC STENOSIS\naortic valve replacement (see criteria below), bal\nloon valvuloplasty (offers no survival benefit and is\nonly a temporizing measure)\nVASODILATORS\nuse with caution in the setting of\nhypertension or HF. ACE inhibitors preferred over b\nblockers because of risk of reduced inotropy; start low\ndose and titrate slowly; risk of hypotension and syncope\nTREATMENT ISSUES\nAORTIC VALVE REPLACEMENT (AVR)\n\u0002\nABSOLUTE INDICATIONS\nsevere aortic stenosis with\nany classic symptoms (angina, syncope, dyspnea)\nor with LV dysfunction, severe aortic stenosis and\nrequire CABG/surgery of aorta/other heart valves\n\u0002\nPOSSIBLE\nINDICATIONS\nmoderate aortic stenosis\nand require CABG/surgery of aorta/other heart\nvalves, asymptomatic severe aortic stenosis and\none of hemodynamic instability during exercise,\nor ventricular tachycardia\n\u0002\nPREOPERATIVE\nCONSULT\nAVR should be done\nbefore elective non cardiac surgeries in sympto\nmatic patients\n\u0002\nRISK OF AVR\nmortality 1 2%, morbidity 1%/year\n(venous thromboembolic disease, bleeding, dete\nrioration of prosthetic valve, endocarditis)\nMECHANICAL VS. BIOPROSTHETIC VALVE\ncom\npared to human tissue valves, mechanical valves have\nprolonged durability, but higher chance of throm\nboembolism and bleeding from chronic anticoagula\ntion. Overall, long term outcomes are better with a\nmechanical valve. Main indications for bioprosthesis\nvalve include patients who cannot or will not tolerate\nwarfarin or for whom compliance is uncertain,\npatients \u000565 years of age who do not have risk\nfactors for thromboembolism, and women of child\nbearing age\nCLINICAL FEATURES (CONT\u2019D)\n48\nAortic Stenosis", "text_length": 3471, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 62/464)", "type": "chunk", "chunk_index": 61, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.320514", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.321565", "status": "complete", "chunks_added": 2}